NCT03423459View on ClinicalTrials.gov

CoreValve Evolut Pro Prospective Registry

UnknownOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

January 18, 2018

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2024

Conditions
Aortic Stenosis
Interventions
DEVICE

TAVR

Transcatheter Aortic Valve Replacement

Trial Locations (2)

20010

MedStar Washington Hospital Center, Washington D.C.

21218

Medstar Union Memorial Hospital, Baltimore

Sponsors

Collaborators (1)

Medtronic Cardiovascular
All Listed Sponsors
collaborator

Medtronic Cardiovascular

INDUSTRY

lead

Medstar Health Research Institute

OTHER

NCT03423459 - CoreValve Evolut Pro Prospective Registry | Biotech Hunter | Biotech Hunter